ロード中...
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its merits of repeatability and non-invasiveness, this method is currently only used as a supplemental test due...
保存先:
| 出版年: | J Pathol Transl Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674759/ https://ncbi.nlm.nih.gov/pubmed/33027851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2020.08.13 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|